Cargando…
Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair
BACKGROUND: Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects of enhancing cancer cell radiosensitivity. PRINCIPAL FINDING: Lung cancer A549 cells and breast cancer MCF-7 cell...
Autores principales: | Qu, Yuan-yuan, Hu, Song-liu, Xu, Xiang-ying, Wang, Rui-zhi, Yu, Hong-yang, Xu, Jian-yu, Chen, Lin, Dong, Guang-lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745376/ https://www.ncbi.nlm.nih.gov/pubmed/23976954 http://dx.doi.org/10.1371/journal.pone.0070727 |
Ejemplares similares
-
Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair
por: Teng, Kai, et al.
Publicado: (2015) -
Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
por: Huang, Jianfeng, et al.
Publicado: (2018) -
Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line
por: Li, Jiancheng, et al.
Publicado: (2019) -
UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
por: Wu, Changyong, et al.
Publicado: (2023) -
Reaction of Electrons with DNA: Radiation Damage to Radiosensitization
por: Kumar, Anil, et al.
Publicado: (2019)